Short answer
Sight Sciences, Inc. (SGHT) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Q3 2026 results announced for quarter ended September 30, 2026.
Sight Sciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 results announced for quarter ended September 30, 2026
- Full-year 2026 revenue guidance raised, signaling improved expected sales performance
- Detailed financial results and revised guidance in Exhibit 99.1 press release
Item 7.01 · Regulation FD Disclosure
- Investor presentation posted November 4, 2026, intended for investor and analyst communications
- Exhibit 99.2 contains the presentation, potentially including updated strategy, operating metrics, or financial guidance
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $24.9M, up 25% year over year, signaling accelerating commercial traction
- IDE revenue $3.9M versus $0.2M, with 222 active customers and 4,581 treatment units sold
- IG revenue $21.0M, up 7%, supported by 1,253 active customers versus 1,197
- Net loss improved to $6.8M from $8.2M, while cash usage fell 74% to $2.4M
- Full-year revenue guidance raised to $92M-$93M, including approximately $12M IDE revenue versus prior guidance of $9M-$11M
Item EX-99.2 · Exhibit EX-99.2
- Q3 2026 revenue $24.9M, up 25% YoY, marking a third consecutive quarter of double-digit growth
- FY2026 revenue guidance $92M-$93M, up 19%-20% YoY, signaling accelerating commercial momentum
- YTD adjusted operating expenses 99% of revenue versus 121% prior year, while cash usage improved 74%
- Interventional dry eye revenue $7.9M versus $0.9M prior year, making TearCare the primary growth engine
- OMNI Ultra launch, Aetna coverage, and expanded commercial targeting represent key catalysts, with reimbursement and execution as principal risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sight Sciences, Inc. 8-K filings
Get the next SGHT 8-K as it lands
Follow SGHT for push alerts, or ask the research agent what this filing means.